BIO-TECHNE Corp — Director's Dealing 2021

Aug 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2021-08-06

Reporting Person: Furlow Brenda S. (SVP - General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-08	Common Stock	M	1374	—	Acquired	7498	Direct
2021-08-08	Common Stock	F	677	$481.82	Disposed	6821	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-08	Restricted Stock Units	$	M	1374	Disposed		Common Stock (1374)	Direct
2021-08-06	Restricted Stock Units	$	A	1167	Acquired		Common Stock (1167)	Direct
2021-08-06	Stock Options (Right to Buy)	$481.82	A	4560	Acquired	2028-08-06	Common Stock (4560)	Direct
2021-08-06	Stock Options (Right to Buy)	$481.82	A	6080	Acquired	2028-08-06	Common Stock (6080)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$108.49	2022-08-07	Common Stock (921)	921	Direct
Stock Options (Right to Buy)	$106.59	2023-08-18	Common Stock (3538)	3538	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (9503)	9503	Direct
Stock Options (Right to Buy)	$125.05	2024-08-09	Common Stock (12670)	12670	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (7339)	7339	Direct
Stock Options (Right to Buy)	$177.32	2025-08-08	Common Stock (9786)	9786	Direct
Restricted Stock Units	$		Common Stock (1969)	1969	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (9968)	9968	Direct
Stock Options (Right to Buy)	$190.41	2026-08-07	Common Stock (13290)	13290	Direct
Restricted Stock Units	$		Common Stock (1679)	1679	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (7492)	7492	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (9990)	9990	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (8325)	8325	Direct
Stock Options (Right to Buy)	$267.87	2027-08-05	Common Stock (8325.0)	8325.0	Direct
Stock Options (Right to Buy)	$372.44	2028-03-01	Common Stock (10997)	10997	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Fully exercisable.

F3: Vested in full on 8/8/2021 upon the certification of achievement of performance goals.

F4: Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.

F5: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.

F7: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F8: Options to purchase 2,498 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,497 shares vest on each of 8/5/2023 and 8/5/2024.

F9: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

F10: Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.

F11: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F12: Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.